Injective Launches Pre-IPO Perpetual Futures for Enterprises, Trading Volume Reaches $1 Billion

Blockchain protocol Injective has introduced on-chain private equity stock derivatives, specifically pre-IPO perpetual futures for enterprises. Through this product, investors can gain exposure to unlisted companies such as OpenAI, SpaceX, Anthropic, and Perplexity. In August of this year, Injective partnered with Republic to promote the democratization of retail investor participation in private enterprise investments. According to the latest data from Injective, the trading volume of its real-world asset (RWA) perpetual futures contracts has exceeded $1 billion over the past 30 days, demonstrating strong market demand for this innovative product.